1. Home
  2. AXSM vs SR Comparison

AXSM vs SR Comparison

Compare AXSM & SR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXSM
  • SR
  • Stock Information
  • Founded
  • AXSM 2012
  • SR 1857
  • Country
  • AXSM United States
  • SR United States
  • Employees
  • AXSM N/A
  • SR N/A
  • Industry
  • AXSM Biotechnology: Pharmaceutical Preparations
  • SR Oil/Gas Transmission
  • Sector
  • AXSM Health Care
  • SR Utilities
  • Exchange
  • AXSM Nasdaq
  • SR Nasdaq
  • Market Cap
  • AXSM 5.1B
  • SR 4.5B
  • IPO Year
  • AXSM 2015
  • SR N/A
  • Fundamental
  • Price
  • AXSM $105.71
  • SR $74.15
  • Analyst Decision
  • AXSM Strong Buy
  • SR Buy
  • Analyst Count
  • AXSM 16
  • SR 9
  • Target Price
  • AXSM $170.50
  • SR $78.22
  • AVG Volume (30 Days)
  • AXSM 694.5K
  • SR 471.7K
  • Earning Date
  • AXSM 08-04-2025
  • SR 07-30-2025
  • Dividend Yield
  • AXSM N/A
  • SR 4.31%
  • EPS Growth
  • AXSM N/A
  • SR N/A
  • EPS
  • AXSM N/A
  • SR 4.09
  • Revenue
  • AXSM $432,157,000.00
  • SR $2,428,300,000.00
  • Revenue This Year
  • AXSM $62.84
  • SR $1.50
  • Revenue Next Year
  • AXSM $60.02
  • SR $5.13
  • P/E Ratio
  • AXSM N/A
  • SR $17.81
  • Revenue Growth
  • AXSM 72.16
  • SR N/A
  • 52 Week Low
  • AXSM $72.21
  • SR $58.64
  • 52 Week High
  • AXSM $139.13
  • SR $79.81
  • Technical
  • Relative Strength Index (RSI)
  • AXSM 48.53
  • SR 45.20
  • Support Level
  • AXSM $99.75
  • SR $72.39
  • Resistance Level
  • AXSM $106.60
  • SR $74.33
  • Average True Range (ATR)
  • AXSM 3.11
  • SR 1.04
  • MACD
  • AXSM 0.10
  • SR 0.04
  • Stochastic Oscillator
  • AXSM 44.39
  • SR 42.78

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

About SR Spire Inc.

Spire Inc is a public utility holding company with three reportable business segments: Gas Utility, Gas Marketing and Midstream. The Gas Utility segment includes the regulated operations of Laclede Gas, Alabama Gas Corporation ('Alagasco') changed its name to Spire Alabama Inc. effective September 1, 2017, and Laclede Gas Company changed its name to Spire Missouri Inc. effective August 30, 2017. The Gas Utility segment generates a majority of the company's revenue but is subject to seasonal fluctuations. The Gas Marketing segment includes Laclede Energy Resources, Inc, whose operations include the marketing of natural gas and related activities on a non-regulated basis and the Midstream segment includes transportation and storage of natural gas. Maximum revenue from residential area.

Share on Social Networks: